Rymedi is a blockchain focused startup that aims to revolutionize the healthcare industry. Founded in 2018, the company's slogan "Empowering life sciences organizations to improve human health" encapsulates its mission to use blockchain technology to enable better management of patient and population healthcare data. Rymedi's offerings include blockchain enabled software designed to support diagnostic and toxicology testing devices companies, clinical trials and registries, laboratory integrations, and secure storage of healthcare data. The startup recently secured a significant $9.00M Series A investment on 25th October 2023, with key investors including White Star Capital, Blockchange Ventures, RW3 Ventures, Founderville, and Blizzard Fund. With its innovative approach and strong investor backing, Rymedi is poised to make a major impact in the healthcare and blockchain sectors.
No recent news or press coverage available for Rymedi.